Event Description

Event Description

Employers must balance population health goals with rising costs and uncertain outcomes when designing an obesity management strategy. Some choose not to cover anti-obesity medications while others cover GLP1s and/or non-GLP1s. Those who cover medications may tighten coverage policies, enforce stricter prior authorizations, and explore alternative therapies and payment models to control costs. Attend this webinar to learn why employers should rethink their approach and align their strategy with that of other chronic diseases. Providing comprehensive coverage of obesity medications provides a more personalized, effective solution for managing obesity, resulting in better outcomes and addresses diverse member needs.

Key Topics Covered:

The impact of obesity and related co-morbidities on employer health care costs
Current weight loss interventions and treatment guidelines from recognized experts
Individualized treatment approaches including how non-GLP1s can fit into a comprehensive obesity management strategy
Real world stories from employers who have adopted different (but effective) approaches to obesity management
Employer action steps to guide evaluation and improvement of current strategies

This program is only available virtually.

Speakers